Research Site — Burlington, North Carolina

Research Site is a clinical research site located in Burlington, North Carolina, United States 27215.

Crixeo Clinical Trials Trust Score: 21/100 (FAILING). This profile has not yet been claimed by the site owner.

Research Site has participated in 20 clinical trials.

Therapeutic areas: Heart Failure With Reduced Ejection Fraction (HFrEF), Diabetes Mellitus, Asthma.

Sponsors: AstraZeneca, Pearl Therapeutics, Inc., Amgen.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Burlington

Browse all research sites in North Carolina · View every site in Burlington

• Cone Health Cancer Center at Alamance Regional
• Alamance Cancer Center at Alamance Regional Medical Center
• Alamance Regional Medical Center
• GSK Investigational Site
• Kernodle Clinic
• Kernodle Clinic West
• Pfizer Investigational Site
• Novo Nordisk Investigational Site
• Alamance Cancer Center
• Laboratory Corporation of America
• Kernodle Clin Dpt-Pvt Diagnost

Sponsor Feasibility Report

Trust Score: 21/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site?

Research Site has a Crixeo Trust Score of 21/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site conducted?

Research Site has 20 clinical trials on record. Their work covers Heart Failure With Reduced Ejection Fraction (HFrEF), Diabetes Mellitus, Asthma.

Is Research Site accredited by Crixeo Clinical Trials?

Research Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Research Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.